Man Group PLC Uro Gen Pharma Ltd. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.99 - $11.02 $14,190 - $19,571	1,776 Added 12.42%	16,076 $148,000
Q4 2022 Feb 14, 2023	BUY	$7.55 - $11.96 $107,965 - $171,028	14,300 New	14,300 $126,000
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $392,813 - $600,676	-16,484 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$32.75 - $40.35 $5.32 Million - $6.56 Million	-162,512 Reduced 90.79%	16,484 $592,000
Q1 2019 May 15, 2019	BUY	$35.47 - $54.55 $2.1 Million - $3.23 Million	59,260 Added 49.49%	178,996 $6.61 Million
Q4 2018 Feb 14, 2019	BUY	$38.35 - $50.39 $505,759 - $664,543	13,188 Added 12.38%	119,736 $5.16 Million
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $3.56 Million - $4.42 Million	85,416 Added 404.2%	106,548 $5.03 Million
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $1.02 Million - $1.38 Million	21,132 New	21,132 $1.05 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $239M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.